1. Committee on Quality of Health Care in America To Err Is Human (2000) Building a Safer Health System. In: Kohn LT, Corrigan JM, Donaldson MS (eds) National Academy Press. Washington, DC
2. Preventable Adverse Drug Reactions: A Focus on Drug Interactions. U.S. Food and Drug Administration. Accessed 30 Oct. 2013. http://www.fda.gov/drugs/developmentapprovalprocess/developmentresources/druginteractionslabeling/ucm110632.htm
3. Gautier S, Bachelet H, Bordet R, Caron J (2003) The cost of adverse drug reactions. Expert Opin Pharmacother 4:319–326
4. U.S. Food and Drug Administration. Guidance for Industry: Safety Testing of Drug Metabolites. Accessed 30 Oct. 2013. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079266.pdf
5. International Conference on Harmonisation. Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2). Accessed 30 Oct 2013. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm073246.pdf